Pharmacokinetics, safety, and efficacy of lenalidomide plus dexamethasone in patients with multiple myeloma and renal impairment (Q39692801)

14 September 2017

title

Pharmacokinetics, safety, and efficacy of lenalidomide plus dexamethasone in patients with multiple myeloma and renal impairment (English)

1 reference

14 September 2017

1 reference

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27286995%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Frank Bridoux

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27286995%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Nianhang Chen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27286995%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Stephane Moreau

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27286995%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Bertrand Arnulf

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27286995%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Eric Moumas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27286995%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Julie Abraham

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27286995%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Estelle Desport

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27286995%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Jean Paul Fermand

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27286995%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

publication date

10 June 2016

1 reference

Cancer Chemotherapy and Pharmacology

14 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27286995%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27286995%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27286995%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

173-182

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27286995%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-3068-9

Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-3068-9

Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-3068-9

Diagnosis of monoclonal gammopathy of renal significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-3068-9

Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-3068-9

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-3068-9

Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-3068-9

Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-3068-9

Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in subjects on hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-3068-9

The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-3068-9

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-3068-9

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-3068-9

Validity of creatinine clearance estimates in the assessment of renal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-3068-9

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-3068-9

International uniform response criteria for multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-3068-9

Successful treatment of patients with multiple myeloma and impaired renal function with lenalidomide: results of 4 German centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-3068-9

Optimizing the treatment of patients with multiple myeloma and renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-3068-9

Activity and safety of lenalidomide and dexamethasone in patients with multiple myeloma requiring dialysis: a Spanish multicenter retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-3068-9

Renal Failure in Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-3068-9

Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-3068-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-016-3068-9

10.1007/S00280-016-3068-9

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27286995%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

1 reference